These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 29789805)

  • 1. In Silico Knockout Screening of
    Oyelade J; Isewon I; Uwoghiren E; Aromolaran O; Oladipupo O
    Biomed Res Int; 2018; 2018():8985718. PubMed ID: 29789805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimating novel potential drug targets of Plasmodium falciparum by analysing the metabolic network of knock-out strains in silico.
    Fatumo S; Plaimas K; Mallm JP; Schramm G; Adebiyi E; Oswald M; Eils R; König R
    Infect Genet Evol; 2009 May; 9(3):351-8. PubMed ID: 18313365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In silico multiple-targets identification for heme detoxification in the human malaria parasite Plasmodium falciparum.
    Phaiphinit S; Pattaradilokrat S; Lursinsap C; Plaimas K
    Infect Genet Evol; 2016 Jan; 37():237-44. PubMed ID: 26626103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An in silico strategy for identification of novel drug targets against Plasmodium falciparum.
    Rout S; Patra NP; Mahapatra RK
    Parasitol Res; 2017 Sep; 116(9):2539-2559. PubMed ID: 28755265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Network-based gene prediction for Plasmodium falciparum malaria towards genetics-based drug discovery.
    Chen Y; Xu R
    BMC Genomics; 2015; 16 Suppl 7(Suppl 7):S9. PubMed ID: 26099491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimalarial drugs and drug targets specific to fatty acid metabolic pathway of Plasmodium falciparum.
    Qidwai T; Khan F
    Chem Biol Drug Des; 2012 Aug; 80(2):155-72. PubMed ID: 22487082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasmodium kinases as targets for new-generation antimalarials.
    Lucet IS; Tobin A; Drewry D; Wilks AF; Doerig C
    Future Med Chem; 2012 Dec; 4(18):2295-310. PubMed ID: 23234552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the Plasmodium vivax equilibrative nucleoside transporter 1 (PvENT1) for antimalarial drug development.
    Deniskin R; Frame IJ; Sosa Y; Akabas MH
    Int J Parasitol Drugs Drug Resist; 2016 Apr; 6(1):1-11. PubMed ID: 26862473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Helicases - feasible antimalarial drug target for Plasmodium falciparum.
    Tuteja R
    FEBS J; 2007 Sep; 274(18):4699-704. PubMed ID: 17824956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Review on Plasmodium falciparum-Protein Farnesyltransferase Inhibitors as Antimalarial Drug Targets.
    Sharma K
    Curr Drug Targets; 2017; 18(14):1676-1686. PubMed ID: 27557819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Transport proteins as drug targets in Plasmodium falciparum. New perspectives in the treatment of malaria].
    Ellekvist P; Colding H
    Ugeskr Laeger; 2006 Mar; 168(13):1314-7. PubMed ID: 16579884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative analysis of drug effects at the whole-body level: a case study for glucose metabolism in malaria patients.
    Snoep JL; Green K; Eicher J; Palm DC; Penkler G; du Toit F; Walters N; Burger R; Westerhoff HV; van Niekerk DD
    Biochem Soc Trans; 2015 Dec; 43(6):1157-63. PubMed ID: 26614654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of phospholipid synthesis in the development and differentiation of malaria parasites in the blood.
    Kilian N; Choi JY; Voelker DR; Ben Mamoun C
    J Biol Chem; 2018 Nov; 293(45):17308-17316. PubMed ID: 30287688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel Methodology for Bioenergetic Analysis of Plasmodium falciparum Reveals a Glucose-Regulated Metabolic Shift and Enables Mode of Action Analyses of Mitochondrial Inhibitors.
    Sakata-Kato T; Wirth DF
    ACS Infect Dis; 2016 Dec; 2(12):903-916. PubMed ID: 27718558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unraveling the importance of the malaria parasite helicases.
    Tuteja R
    FEBS J; 2017 Aug; 284(16):2592-2603. PubMed ID: 28500788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ImmunoPEGliposomes for the targeted delivery of novel lipophilic drugs to red blood cells in a falciparum malaria murine model.
    Moles E; Galiano S; Gomes A; Quiliano M; Teixeira C; Aldana I; Gomes P; Fernàndez-Busquets X
    Biomaterials; 2017 Nov; 145():178-191. PubMed ID: 28869864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malarial kinases: novel targets for in silico approaches to drug discovery.
    Bullard KM; DeLisle RK; Keenan SM
    Methods Mol Biol; 2013; 993():205-29. PubMed ID: 23568473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasmodium falciparum: new molecular targets with potential for antimalarial drug development.
    Gardiner DL; Skinner-Adams TS; Brown CL; Andrews KT; Stack CM; McCarthy JS; Dalton JP; Trenholme KR
    Expert Rev Anti Infect Ther; 2009 Nov; 7(9):1087-98. PubMed ID: 19883329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can a single "powerless" mitochondrion in the malaria parasite contribute to parasite programmed cell death in the asexual stages?
    Ch'ng JH; Yeo SP; Shyong-Wei Tan K
    Mitochondrion; 2013 May; 13(3):254-6. PubMed ID: 23123916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimalarial drug targets in Plasmodium falciparum predicted by stage-specific metabolic network analysis.
    Huthmacher C; Hoppe A; Bulik S; Holzhütter HG
    BMC Syst Biol; 2010 Aug; 4():120. PubMed ID: 20807400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.